Pharmaceutical sector roundup: UR AssociatesMoneycontrol.comThe original form of the drug is called Rituximab, and is sold by its innovator Roche AG. Reddy's effort to launch the world's first MAb “biosimilar” is expected to happen jointly …

Spectrum Pharmaceuticals: Raj Sets The Record Straight And Quiets The …Seeking AlphaHe acknowledged that logistical issues and certain requirements for physicians have limited the sales of Zevalin. He compared the drug with the blockbuster lymphoma d…

Emcure to make, market Roche productsHindu Business LineThe second is Rituximab, sold as Mabthera, a drug for non-Hodgkin's lymphoma and rheumatoid arthritis. Similarly, this partnership will be extended to Roche's patented products in India cu…

Clinical Oncology NewsAssistant Director Hematology & Stem Cell Transplantation ProgramClinical Oncology NewsThe Study Group Indolent Lymphomas (StiL) NHL1 trial demonstrated a progression-free survival (PFS) benefit and improved tolerability with …

Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears …Business Wire (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on th…

Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears …EON: Enhanced Online News (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN …

ALLOS THERAPEUTICS, INC. : Spectrum Pharmaceuticals and Allos …4-tradersThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of a targeted…

Non-Hodgkin's lymphoma and chronic lymphocytic leukaemiaPharmacy EuropeTreanda is approved in patients with chronic lymphocytic leukaemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lym…

LUNDBECK : receives approval from Health Canada for Treanda …4-tradersTreanda is approved in patients with chronic lymphocytic leukemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lymphom…

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 …7thSpace Interactive (press release)Indolent lymphoma (IL), the second most common lymphoma, remains incurable with chemotherapy alone. While R-CHOP (rituximab, cyclophospham…